ARCHIVES

NIH Consensus Conference Agenda, Registration Online.

This article is from The Cancer Letter archive.

Vol. 26 No. 31 | September 1, 2000

Download PDF Visit The Full Archive

Related Articles

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

June 10, 1983

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011